tradingkey.logo

Apyx Medical Corp

APYX
3.680USD
+0.190+5.44%
交易中 美东报价延迟15分钟
139.18M总市值
亏损市盈率 TTM

Apyx Medical Corp

3.680
+0.190+5.44%

关于 Apyx Medical Corp 公司

Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.

Apyx Medical Corp简介

公司代码APYX
公司名称Apyx Medical Corp
上市日期Jul 22, 1983
CEOGoodwin (Charles D)
员工数量220
证券类型Ordinary Share
年结日Jul 22
公司地址5115 Ulmerton Rd
城市CLEARWATER
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编33760-4004
电话18005372790
网址https://apyxmedical.com/
公司代码APYX
上市日期Jul 22, 1983
CEOGoodwin (Charles D)

Apyx Medical Corp公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--
Ms. Wendy Levine
Ms. Wendy Levine
Independent Director
Independent Director
--
--
Mr. Charles D. Goodwin, II
Mr. Charles D. Goodwin, II
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Stavros G. Vizirgianakis
Mr. Stavros G. Vizirgianakis
Independent Chairman of the Board
Independent Chairman of the Board
1.75M
--
Mr. Moshe Citronowicz
Mr. Moshe Citronowicz
Senior Vice President
Senior Vice President
456.50K
--
Mr. Lawrence J. (Larry) Waldman, CPA
Mr. Lawrence J. (Larry) Waldman, CPA
Lead Independent Director
Lead Independent Director
42.90K
--
Mr. Matthew C. (Matt) Hill
Mr. Matthew C. (Matt) Hill
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
8.50K
--
Mr. Shawn David Roman
Mr. Shawn David Roman
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
Domestic
7.78M
68.37%
International
3.60M
31.63%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
6.03%
Vizirgianakis (Stavros G)
4.26%
其他
65.87%
持股股东
持股股东
占比
Nantahala Capital Management, LLC
8.14%
Archon Capital Management LLC
8.00%
Vanderfelt (William Weeks)
7.70%
Royce Investment Partners
6.03%
Vizirgianakis (Stavros G)
4.26%
其他
65.87%
股东类型
持股股东
占比
Hedge Fund
17.02%
Individual Investor
13.42%
Investment Advisor
11.62%
Investment Advisor/Hedge Fund
8.99%
Private Equity
0.37%
Family Office
0.23%
Research Firm
0.10%
Venture Capital
0.05%
其他
48.19%

机构持股

更新时间: 12月8日 周一
更新时间: 12月8日 周一
报告期
机构数
持股数
持股占比
持股变动
2025Q4
93
15.65M
47.11%
--
2025Q3
106
16.17M
54.10%
-179.30K
2025Q2
111
16.35M
54.58%
+38.20K
2025Q1
115
16.92M
61.27%
-6.24M
2024Q4
121
17.05M
55.05%
+3.13M
2024Q3
126
13.93M
65.05%
-228.66K
2024Q2
141
15.10M
68.01%
-305.66K
2024Q1
168
15.41M
70.58%
-9.04M
2023Q4
180
18.49M
72.63%
-941.37K
2023Q3
175
19.43M
74.54%
-988.75K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Nantahala Capital Management, LLC
3.34M
8.83%
+80.00K
+2.46%
Jun 30, 2025
Archon Capital Management LLC
3.28M
8.68%
-15.26K
-0.46%
Jun 30, 2025
Vanderfelt (William Weeks)
3.16M
8.35%
--
--
Jun 23, 2025
Royce Investment Partners
2.44M
6.45%
-85.76K
-3.40%
Jun 30, 2025
Vizirgianakis (Stavros G)
1.75M
4.62%
--
--
Jun 23, 2025
The Vanguard Group, Inc.
1.48M
3.9%
--
--
Jun 30, 2025
Silverberg Bernstein Capital Management, LLC
986.50K
2.61%
+89.77K
+10.01%
Sep 30, 2025
Commonwealth Financial Network
663.54K
1.75%
+78.00K
+13.32%
Jun 30, 2025
Horizon Kinetics LLC
615.00K
1.63%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
495.99K
1.31%
+6.87K
+1.40%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0.02%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
占比0.02%
Avantis US Equity ETF
占比0%
Avantis US Small Cap Equity ETF
占比0%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Apyx Medical Corp的前五大股东是谁?

Apyx Medical Corp 的前五大股东如下:
Nantahala Capital Management, LLC持有股份:3.34M,占总股份比例:8.83%。
Archon Capital Management LLC持有股份:3.28M,占总股份比例:8.68%。
Vanderfelt (William Weeks)持有股份:3.16M,占总股份比例:8.35%。
Royce Investment Partners持有股份:2.44M,占总股份比例:6.45%。
Vizirgianakis (Stavros G)持有股份:1.75M,占总股份比例:4.62%。

Apyx Medical Corp的前三大股东类型是什么?

Apyx Medical Corp 的前三大股东类型分别是:
Nantahala Capital Management, LLC
Archon Capital Management LLC
Vanderfelt (William Weeks)

有多少机构持有Apyx Medical Corp(APYX)的股份?

截至2025Q4,共有93家机构持有Apyx Medical Corp的股份,合计持有的股份价值约为15.65M,占公司总股份的47.11%。与2025Q3相比,机构持股有所增加,增幅为-6.99%。

哪个业务部门对Apyx Medical Corp的收入贡献最大?

在FY2025Q2,--业务部门对Apyx Medical Corp的收入贡献最大,创收--,占总收入的--%。
KeyAI